NDC Code(s) : 0338-0017-10, 0338-0017-41, 0338-0017-11, 0338-0017-31, 0338-0017-48, 0338-0017-18, 0338-0017-38, 0338-0017-01, 0338-0017-02, 0338-0017-03, 0338-0017-04, 0338-0023-02, 0338-0023-03, 0338-0023-04
Packager : Baxter Healthcare Corporation
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
DEXTROSEDEXTROSE MONOHYDRATE INJECTION, SOLUTION | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DEXTROSEDEXTROSE MONOHYDRATE INJECTION, SOLUTION | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
LABELER - Baxter Healthcare Corporation(005083209) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Baxter Healthcare Corporation | 059140764 | ANALYSIS(0338-0017, 0338-0023), MANUFACTURE(0338-0017, 0338-0023), LABEL(0338-0017, 0338-0023), PACK(0338-0017, 0338-0023), STERILIZE(0338-0017, 0338-0023) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Baxter Healthcare Corporation | 194684502 | ANALYSIS(0338-0017, 0338-0023) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Baxter Healthcare Corporation | 091171389 | ANALYSIS(0338-0017), MANUFACTURE(0338-0017), LABEL(0338-0017), PACK(0338-0017), STERILIZE(0338-0017) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Baxter Healthcare Corporation | 189326168 | ANALYSIS(0338-0017, 0338-0023), MANUFACTURE(0338-0017, 0338-0023), LABEL(0338-0017, 0338-0023), PACK(0338-0017, 0338-0023), STERILIZE(0338-0017, 0338-0023) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Baxter, S.A. de C.V. | 810432484 | ANALYSIS(0338-0017), MANUFACTURE(0338-0017), LABEL(0338-0017), PACK(0338-0017), STERILIZE(0338-0017) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Bieffe Medital SA | 464755693 | ANALYSIS(0338-0017), LABEL(0338-0017), MANUFACTURE(0338-0017), PACK(0338-0017), STERILIZE(0338-0017) |
PRINCIPAL DISPLAY PANEL

Container Label
LOT
EXP
5% Dextrose
Injection USP
2B0061
NDC 0038-0017-01
150 mL
Each 100 mL contains
5 g DextroseHydrous
USP pH 4.0 (3.2 to 6.5)
Osmolarity 252 mOsmol/L (calc)
SterileNonpyrogenic Single dose
container Read package insert for full
information Additives may be
incompatible Dosage Intravenously as
directed by a physician Cautions
Squeeze and inspect inner bag which
maintains product sterility Discard if
leaks are found Must not be used in
series connections Do not administer
simultaneously with blood Do not
useunless solution is clear Rx Only
Store unit in moisture barrier overwrap
at room temperature(25°C/77°F) until
ready to use Avoid excessive heat See
insert
Viaflex container PL146 plastic
BAXTER VIAFLEX and PL 146 are
trademarks of Baxter International Inc
For product information 1-800-933-0303
Baxter
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
Made in USA

Container Label
LOT
EXP
2B0063
NDC 0038-0023-03
DIN 00060364
10% Dextrose
Injection USP
500 mL
Each 100 mL contain 10 g Dextrose Hydrous USP
pH 4.0 (3.2 to 6.5) Hypertonic Osmolarity 505
mOsmol/L (calc) Sterile Nonpyrogenic Single dose
container Additives may be incompatible Consult with
pharmacist if available When introducing additives use
aseptic technique Mix thorouhly Do not store
Dosage Intravenously as directed by a physician See
cirections Cautions Squeeze and inspect inner bag
which maintains product sterility Discard if leaks are
found Must not be used in series connections Do not
administer simultaneously with blood Do not use
unless solution is clear Rx Only Store unit in
moisture barrier overwrap at room temperature
(25°C/77°F) until ready to use Avoid excessive heat
See insert
Viaflex container PL 146 plastic
BAXTER VIAFLEX and PL 146 are trademarks of
Baxter International Inc
For product information 1-800-933-0303
Baxter logo
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
Made in USA
Distribute in Canada By
Baxter Corporation
Toronto Ontario Canada